Holen Sie sich die Stockscreener-App
1.95
3.17%
0.06
Finanzdaten der Grace Therapeutics Inc-Aktie (GRCE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
65.95%
0.697
|
0.42 | 0.462 | 0.568 | 0.955 |
| Operating Income/Loss |
428.80%
-15.92
|
-3.01 | -2.449 | -2.529 | -3.09 |
| Nonoperating Income/Loss |
3.79%
0.127
|
0.132 | 0.134 | 1.591 | -0.272 |
| Income/Loss From Continuing Operations Before Tax |
448.64%
-15.79
|
-2.878 | -2.315 | -0.938 | -3.362 |
| Income Tax Expense/Benefit |
100.00%
-
|
-1.70 | - | - | - |
| Net Income/Loss |
1,240%
-15.79
|
-1.178 | -2.315 | -0.938 | -3.362 |
| Basic Average Shares |
17.27
|
- | 16.93 | 15.92 | 15.92 |
| Diluted Average Shares |
17.27
|
- | 16.93 | 15.92 | 15.92 |
| Basic Earnings Per Share |
-0.91
|
- | -0.14 | -0.06 | -0.21 |
| Diluted Earnings Per Share |
-0.91
|
- | -0.14 | -0.06 | -0.21 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):